NBSE - NeuBase Therapeutics Inc Stock Price, Fair Value and News
$0.38
Market Closed as of 24 May 2024, 04:00 pm ET
NBSE Stock Valuation Analysis
Valuation
Login to View
Max Portfolio %
Login to View
NBSE Price Action
NBSE RSI Chart
NBSE Stock Valuation Analysis
Valuation
Login to View
Max Portfolio %
Login to View
NBSE Valuation
The Good, Bad and Ugly
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
NBSE Fundamentals
NBSE Revenue
NBSE Earnings
NBSE Profitability
NBSE Investor Care
Revenue & Growth
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2023 | 469.8K | 548.7K | 605.0K | - |
| 2022 | 7.8K | 42.9K | 148.6K | 294.9K |
| 2021 | - | - | 363.3K | 13.8K |
| 2011 | - | - | - | - |
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
| CEO | Dr. Dietrich A. Stephan Ph.D. |
|---|---|
| WEBSITE | neubasetherapeutics.com |
| SECTOR | Healthcare |
| INDUSTRY | Biotechnology |
| EMPLOYEES | 37 |